--- res: bibo_abstract: - Drugs that block the entry of human immunodeficiency virus type 1 (HIV-1) into host cells abrogate the establishment of a productive infection and should ideally diminish the chances of HIV-1 developing resistance. This review will give an overview of the mechanism by which the envelope glycoprotein mediates HIV-1 entry and will summarize current drug developments.@eng bibo_authorlist: - foaf_Person: foaf_givenName: Sandra foaf_name: Sandra Siegert foaf_surname: Siegert foaf_workInfoHomepage: http://www.librecat.org/personId=36ACD32E-F248-11E8-B48F-1D18A9856A87 orcid: 0000-0001-8635-0877 - foaf_Person: foaf_givenName: Peter foaf_name: Schnierle, Peter foaf_surname: Schnierle - foaf_Person: foaf_givenName: Barbara foaf_name: Schnierle, Barbara S foaf_surname: Schnierle bibo_doi: 10.2174/138955706776876267 bibo_issue: '5' bibo_volume: 6 dct_date: 2006^xs_gYear dct_publisher: Bentham Science Publishers@ dct_title: 'Novel anti-viral therapy: Drugs that block HIV entry at different target sites@' ...